Marianna Mancini Viking Therapeutics, Inc. (VKTX) insider trading activity

Marianna Mancini is Chief Operating Officer of Viking Therapeutics, Inc.. Currently has a direct ownership of 362,149 shares of VKTX, which is worth approximately $15.3 Million. The most recent transaction as insider was on Dec 30, 2022, when has been sold 12,773 shares (Common stock, par value $0.00001 per share) at a price of $9.4 per share, resulting in proceeds of $120,066. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 362K

0% 3M change

25.85% 12M change

Total Value Held $15.3 Million

Marianna Mancini Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 30 2022	SELL Payment of exercise price or tax liability	$120,066 $9.4 p/Share	12,773 Reduced 4.67%	260,533 Common stock, par valu...
Dec 30 2022	BUY Grant, award, or other acquisition	-	23,500 Added 7.92%	273,306 Common stock, par valu...
Jan 15 2022	SELL Payment of exercise price or tax liability	$3,506 $4.24 p/Share	827 Reduced 0.35%	238,695 Common stock, par valu...
Jan 04 2022	SELL Payment of exercise price or tax liability	$54,724 $4.62 p/Share	11,845 Reduced 4.71%	239,522 Common stock, par valu...
Jan 03 2022	SELL Payment of exercise price or tax liability	$19,125 $4.88 p/Share	3,919 Reduced 2.2%	174,034 Common stock, par valu...
Jan 03 2022	BUY Grant, award, or other acquisition	-	77,333 Added 23.53%	251,367 Common stock, par valu...
Sep 28 2021	SELL Payment of exercise price or tax liability	$18,454 $6.5 p/Share	2,839 Reduced 1.57%	177,535 Common stock, par valu...
Sep 28 2021	BUY Grant, award, or other acquisition	-	6,667 Added 3.56%	180,374 Common stock, par valu...
Jan 19 2021	SELL Payment of exercise price or tax liability	$6,640 $6.68 p/Share	994 Reduced 0.58%	169,952 Common stock, par valu...
Jan 15 2021	SELL Payment of exercise price or tax liability	$4,445 $6.48 p/Share	686 Reduced 0.4%	170,946 Common stock, par valu...
Jan 04 2021	SELL Payment of exercise price or tax liability	$16,083 $5.8 p/Share	2,773 Reduced 1.59%	171,632 Common stock, par valu...
Jan 04 2021	BUY Grant, award, or other acquisition	-	79,750 Added 31.38%	174,405 Common stock, par valu...

Marianna Mancini

Chief Operating Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VKTX shares.

Notify only if

Value

Insider Trading

Get notified when an Viking Therapeutics, Inc. insider buys or sells VKTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Viking Therapeutics, Inc.

Track Activities on VKTX

Account